We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-7.57%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.52B
AUM Growth
+$35M
Cap. Flow
+$831M
Cap. Flow %
23.65%
Top 10 Hldgs %
38.14%
Holding
2,292
New
549
Increased
398
Reduced
416
Closed
501
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPAXU
1401
DELISTED
Inflection Point Acquisition Corp. Units
IPAXU
$98K ﹤0.01%
10,000
GLHA
1402
DELISTED
Glass Houses Acquisition Corp. Class A common stock
GLHA
$98K ﹤0.01%
10,000
TSPQ
1403
DELISTED
TCW Special Purpose Acquisition Corp.
TSPQ
$98K ﹤0.01%
10,000
CRU
1404
DELISTED
Crucible Acquisition Corporation
CRU
$98K ﹤0.01%
10,000
LONA
1405
LeonaBio Inc
LONA
$70.5M
$97K ﹤0.01%
3,180
+2,080
+189% +$191K
CD
1406
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
$96K ﹤0.01%
+12,393
New +$79.9K
EXTN
1407
DELISTED
Exterran Corporation
EXTN
$96K ﹤0.01%
22,370
+8,121
+57% +$49.1K
EAF icon
1408
GrafTech
EAF
$205M
$95K ﹤0.01%
+1,340
New +$117K
APRN
1409
PUT
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$95K ﹤0.01%
+2,167
New +$88.2K
ENZ
1410
DELISTED
Enzo Biochem, Inc.
ENZ
$94K ﹤0.01%
45,500
RNW icon
1411
ReNew
RNW
$2.23B
$93K ﹤0.01%
+14,371
New +$104K
EOSE icon
1412
Eos Energy Enterprises
EOSE
$1.47B
$90K ﹤0.01%
+74,000
New +$152K
TGTX icon
1413
CALL
TG Therapeutics
TGTX
$7.52B
$89K ﹤0.01%
20,900
-200
-0.9% -$1.25K
NVRI icon
1414
Enviri
NVRI
$615M
$88K ﹤0.01%
+12,320
New +$111K
ABOS icon
1415
Acumen Pharmaceuticals
ABOS
$176M
$87K ﹤0.01%
18,500
+2,900
+19% +$10.9K
SKIL icon
1416
Skillsoft
SKIL
$83.5M
$87K ﹤0.01%
1,239
-570
-32% -$58.8K
SBDS
1417
DELISTED
Solo Brands Inc
SBDS
$87K ﹤0.01%
+538
New +$118K
CERS icon
1418
Cerus
CERS
$508M
$84K ﹤0.01%
15,819
-8,061
-34% -$40.3K
TLYS icon
1419
Tilly's
TLYS
$130M
$84K ﹤0.01%
11,942
-11,493
-49% -$95.9K
STCN
1420
DELISTED
Steel Connect, Inc. Common Stock
STCN
$84K ﹤0.01%
+6,732
New +$80K
KLTR icon
1421
Kaltura
KLTR
$250M
$83K ﹤0.01%
41,500
+2,068
+5% +$3.54K
VERO
1422
DELISTED
Venus Concept
VERO
$82K ﹤0.01%
1,074
BRSP
1423
BrightSpire Capital
BRSP
$620M
$80K ﹤0.01%
+10,648
New +$90.2K
FFAI
1424
CALL
Faraday Future Intelligent Electric
FFAI
$11.2M
0
BHR
1425
CALL
Braemar Hotels & Resorts
BHR
$139M
$79K ﹤0.01%
18,300

Similar funds

Prelude Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Prelude Capital Management held 2,292 positions worth $3.52B, up 1% from $3.48B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Prelude Capital Management deployed $831M of net new capital in Q2 2022, opening 549 new positions and adding to 398 existing holdings. Its largest new stake was SM Energy: 2,001,257 shares worth $1.94M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 14% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was TSMC, an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q2 2022 buy was SM Energy: 2,001,257 shares worth $1.94M.
  • Prelude Capital Management added most to Lockheed Martin in Q2 2022, an estimated $85.8M increase.
  • Prelude Capital Management's biggest Q2 2022 reduction was TSMC, cutting an estimated $13.2M.
  • Prelude Capital Management fully exited KKR Acquisition Holdings I Corp. in Q2 2022, selling an estimated $42M.
  • Prelude Capital Management's ten largest holdings make up 38% of its $3.52B portfolio in Q2 2022.
  • Prelude Capital Management opened 549 new positions and closed 501 in Q2 2022.
  • Prelude Capital Management's portfolio value rose 1% quarter-over-quarter to $3.52B.

Based on Prelude Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.